Join us at the world-leading CRUK Cambridge Institute. We're a unique department of the University of Cambridge, core funded by Cancer Reserch UK's charitable activities, and we're eagerly searching for a Research Data Manager to join our IT and Scientific Computing team.
We’re looking for a Deputy Pharmaceutical Production Manager for the new Faecal Microbiota Transplant (FMT) Facility at the Quadram Institute.
We are seeking to appoint a Deputy Pharmaceutical Production Manager with an interest in human studies to investigate the application of Faecal Microbiota Transplant (FMT) for the treatment of gastrointestinal disorders and other microbiome associated diseases to join the existing FMT Team.
Pioneer Group, a specialist life science infrastructure and venture building business, and Firoka, a hospitality and real estate group, have secured unanimous resolution to grant planning permission for the transformation of Ozone Leisure Park in Oxford.
The decision marks a major milestone for Ozone Oxford, a new mixed-use campus that will bring together research, workspace, leisure and community facilities on the existing Ozone Leisure Park site.
As the UK’s leading dementia research charity, we’re determined to stop this from becoming a reality. We’re working to revolutionise the way we treat, diagnose and prevent dementia. But we will not stop there. With your support, we will keep going until every person is free from the heartbreak of dementia. We exist for a cure.
We are seeking an ambitious and experienced cell biologist to join our neuroscience and iPSC team at Arctoris. a fast-growing drug discovery services company based on Milton Park in Abingdon, Oxfordshire. The successful candidate will be a highly experienced, hands-on cell biologist with a strong track record of delivering complex biological projects in a commercial drug discovery setting. They will play a crucial role in all aspects of both our client-focused work and collaborative discovery and automation projects.
About us
Are you passionate about the immune system and its potential to transform therapies? Want to work across diverse, cutting-edge drug discovery projects with Biotech and Pharma clients?
We’re looking for a Senior Scientist to join our growing, collaborative team.
About Us
We are a specialist preclinical immunology CRO, partnering with Biotech and Pharma to accelerate drug development. Our work spans:
*Guest blog by Pivotal. For more information on the information in this blog post please contact Ms. Natalia Farr - [email protected]. If you would like to submit a guest blog please email [email protected].
Tatiana Dicenzo, Senior Regulatory Associate – Pivotal
Fast-track clinical trial procedures in the EU: turning complexity into opportunity
A Supportive Membership Offer While You Plan Your Next Step: One Nucleus Creates a New Membership Category for
Those Who Find Themselves Between Life Science Jobs
Cambridge UK: 15 July 2026
EPO oppositions remain one of the most powerful tools for challenging the validity of a European patent after grant. They offer a centralised and cost-effective route to attack any European patent with effect across all 40 EPC contracting states.
In this webinar, J A Kemp’s experienced European patent attorneys will provide practical insights into EPO opposition practice and potential procedural pitfalls to guard against or exploit, drawing on their extensive experience in both attacking and defending patents before the EPO.
Topics covered include:
Supplementary Protection Certificates are a vital tool for extending protection for authorised human and veterinary medicinal products. Yet the SPC landscape remains complex, fast-moving and often difficult to navigate.
Although the SPC Regulation sets out only four core requirements for grant, each has generated significant legal debate and repeated referrals to the CJEU. Recent legal and political developments continue to shape how these requirements are interpreted.